ID
45165
Beschrijving
Principal Investigator: Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA MeSH: Diabetic Nephropathies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000302 A collection of patients with type-2 diabetes was collected at the Joslin Diabetes Center. Patients were categorized to a group of cases with diabetic nephropathy, and a group of controls with normoalbuminuria. From these groups, 173 cases and 177 controls were randomly selected for a genome-wide association study.
Link
Trefwoorden
Versies (2)
- 25-08-22 25-08-22 - Chiara Middel
- 12-10-22 12-10-22 - Adrian Schulz
Houder van rechten
Andrzej Krolewski, MD, PhD, Joslin Diabetes Center, Boston, MA, USA
Geüploaded op
12 oktober 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000302 Genetic Study on Nephropathy in Type-2 Diabetes
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Subject - Sample Mapping
- The dataset contains general diabetes 2 phenotype information including participants' case/control status (case: ESRD or proteinuria or microalbuminuria and chronic kidney disease [CKD] stage 4 or 5; control: normoalbuminuria, CKD Stage 1 or 2, at least 3 years duration and HbA1c of at least 6%), hemoglobin A1c values at study begin, BMI values, age of diabetes onset and duration etc., and general demographic information.
C2700446 (UMLS CUI [1,2])
C1828181 (UMLS CUI [2,1])
C1298908 (UMLS CUI [2,2])
C0745343 (UMLS CUI [2,3])
C1828181 (UMLS CUI [3,1])
C0205087 (UMLS CUI [3,2])
C1704686 (UMLS CUI [3,3])
C0745343 (UMLS CUI [3,4])
C0022658 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,2])
C0205307 (UMLS CUI [1,2])
C2316786 (UMLS CUI [1,2])
C0011849 (UMLS CUI [1,2])
C1698493 (UMLS CUI [1,2])
C0854078 (UMLS CUI [2,1])
C0730345 (UMLS CUI [3,1])
C2317473 (UMLS CUI [4,1])
C2316810 (UMLS CUI [4,2])